ARTICLE | Product Development
How AI can meet the moment
AI experts weigh in on what’s needed to make the most of the pandemic’s accelerating effects
August 21, 2020 9:38 PM UTC
As COVID-19 makes AI’s efficiencies more critical than ever for drug development, a panel of industry leaders outlines what is needed for the field to fulfill its promises.
In a conversation at the 2020 Life Science Innovation Northwest virtual conference, BioCentury VP and Editor in Chief Simone Fishburn, Concerto HealthAI CEO Jeff Elton, Sage Bionetworks president Lara Mangravite and Biomatics Capital Partners managing partner Julie Sunderland discussed the growing demand for AI applications during the COVID-19 pandemic, and the best practices and rate-limiting factors that need to be addressed for practitioners to succeed. ...